Posts By Alex
-
696Wire Storiesnusilica Glass Foot File �yourb� to Safely Remove Hard Foot Calluses
SEOUL, South Korea–(BUSINESS WIRE)–#FootCallusRemover–In the dry season of winter, yourb, a foot callus remover from nusilica Co., Inc., is selling well to...
-
852Wire Stories
Kerala CM inaugurates The Gender Park Campus after successful completion of global meet on gender equality
KOZHIKODE, Kerala, India–(BUSINESS WIRE)–#ICGEII–The Gender Campus in Kozhikode, Kerala was inaugurated by Chief Minister of Kerala Pinarayi Vijayan on Feb 14th. The...
-
714Wire Stories
Kerala CM inaugurates The Gender Park Campus after successful completion of global meet on gender equality
KOZHIKODE, Kerala, India–(BUSINESS WIRE)–#ICGEII–The Gender Campus in Kozhikode, Kerala was inaugurated by Chief Minister of Kerala Pinarayi Vijayan on Feb 14th. The...
-
675Wire Stories
Alchemy Partners Instpower to Enable Crypto Payments Across Global Network of Power Bank Sharing Stations
SINGAPORE–(BUSINESS WIRE)–Alchemy Pay, the world�s first decentralized finance (DeFi) hybrid fiat and crypto payment solution provider, has partnered with Instpower, a global...
-
610Wire Stories
SBB Research Group Names Three Chicago Nonprofits as February 2021 Grant Finalists
CHICAGO–(BUSINESS WIRE)–SBB Research Group LLC is pleased to announce three Chicago-area charities as the February 2021 finalists of its monthly grant program...
-
717Wire Stories
Royal Farms Offering Employees Wellness Bonus for Vaccination
BALTIMORE, Md., Feb. 12, 2021 (GLOBE NEWSWIRE) — Royal Farms today announced it will pay a $50 wellness bonus to each employee...
-
639Wire Stories
YFDAI Concludes First Governance Vote to Introduce New SST Token and NFTs
SINGAPORE–(BUSINESS WIRE)–YFDAI Finance, a permissionless decentralized finance (DeFi) ecosystem, has officially announced the results of their first community governance vote, which resulted...
-
650Wire Stories
Seagen and Astellas Announce Presentation of Results from PADCEV� (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced Urothelial Cancer Who Were Ineligible for Cisplatin Chemotherapy
– Durable Tumor Responses Experienced Among Patients Previously Treated with Immunotherapy in Second Cohort of EV-201 Trial – – Data Presented in...
-
756Wire Stories
Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV� (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer
– Findings from the EV-301 Trial Showed Significant Improvements in Overall Survival and Progression-Free Survival Compared to Chemotherapy – – EV-301 Intended...
-
1.0KWire Stories
No Dogs Left Behind Meat Market Survivors Coming Home
29 adopted dogs will be flying into LAX February 13th, then heading to JFK Media is invited to attend both events Funds...
